Cancer Drug Discovery & Preclinical Development
17 - 18 Sep 2014
TBA, London, United Kingdom of Great Britain and Northern Ireland
This keystone event will focus on the early stages of cancer drug research, with interactive debate and detailed presentations on a wide range of topics. A diverse line-up of academic and industry experts will be there to ensure fair and balanced coverage of the latest developments in the field. All this takes place in a friendly environment designed to encourage networking between attendees.
Conference Agenda
Hear in-depth presentations on a range of key issues of interest to those working in early stage oncology research and development. Topics include:
-
Improving the Efficiency and Effectiveness of Cancer Drug Discovery
-
Building and Maintaining Industry-Academia Alliances in Oncology
-
Acquired Resistance to Targeted Kinase Inhibitors – Causes, Consequences & Solutions
-
Discovery of a Novel Inhibitor of mTOR Pathway in Clinical Development
-
Novel RNA Oligonucleotide that Inhibits Liver Carcinogenesis In Vivo
-
Using Preclinical Data to Inform Clinical Dose & Schedule in Cancer Drug Trials
-
Using Multi-Scale Modelling to Support Preclinical Developments
-
Preclinical Models for Drug Discovery & Translating Combination Approaches to Clinical Trials
No items were found.